07:01 AM EST, 02/05/2025 (MT Newswires) -- Boston Scientific ( BSX ) reported Q4 adjusted earnings Wednesday of $0.70 per share, up from $0.55 a year earlier.

Two analysts polled by FactSet expected $0.66.

Net sales for the quarter ended Dec. 31 were $4.56 billion, compared with $3.73 billion a year earlier.

Analysts polled by FactSet expected $4.42 billion.

The company said it expects Q1 adjusted EPS of $0.66 to $0.68. Two analysts polled by FactSet expect $0.61.

Boston Scientific ( BSX ) expects full-year adjusted EPS of $2.80 to $2.87. Three analysts polled by FactSet expect $2.24.